Salmonella – still a threat? Epidemiological analysis of infecion
DOI:
https://doi.org/10.12775/JEHS.2021.11.08.004Keywords
salmonella infections, salmonella typhi, salmonella paratyphiAbstract
Salmonella infection causes morbidity and mortality throughout the world with the host immune response varying depending on whether the infection is acute and limited, or systemic and chronic. Global Salmonella infection, especially in developing countries, is a health and economic burden. These pathogen are responsible for millions of cases of food-borne illness each year, with substantial costs measured in hospitalizations and lost productivity. The growing number of bacteria resistant to the antibiotics commonly used to treat infections with this bacterium increases the use of alternative treatments. The species Lactobacillus and Bifidobacterium are the most commonly used probiotics to treat infectious diseases, including antibiotic diarrhea and traveler's diarrhea.
It is a Gram-negative, non-spore-forming, rod-shaped and facultative anaerobic bacterium. However, they have the ability to survive inside infected cells. These bacteria cause various clinical forms of disease. The most dangerous sticks of typhoid fever (Salmonella typhi) and paradurium (Salmonella paratyphi) multiply only in the human body and cause a very serious infectious disease - typhoid fever. In turn, non-malignant salmonella, Salmonella bongori and countless serological varieties of Salmonella enterica colonize the digestive tract of many animal species and are pathogenic to humans, causing gastroenteritis, i.e. acute salmonellosis, sometimes classified as food poisoning. All Salmonella infections begin with ingestion with contaminated food or water.
References
Pucciarelli MG, García-Del Portillo F. Salmonella Intracellular Lifestyles and Their Impact on Host-to-Host Transmission. Microbiol Spectr. lipiec 2017;5(4).
Sajda K. Salmonellozy. Salmonellosis [Internet]. 16 wrzesień 2013 [cytowane 20 lipiec 2021]; Dostępne na: https://ruj.uj.edu.pl/xmlui/handle/item/185895
Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM. Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. Clin Microbiol Rev. październik 2015;28(4):901–37.
Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 30 czerwiec 2012;379(9835):2489–99.
Salmonella , Shigella , and Yersinia - ClinicalKey [Internet]. [cytowane 26 lipiec 2021]. Dostępne na: https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0272271215000219?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0272271215000219%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F
Bula-Rudas FJ, Rathore MH, Maraqa NF. Salmonella Infections in Childhood. Advances in Pediatrics. 1 sierpień 2015;62(1):29–58.
Gut AM, Vasiljevic T, Yeager T, Donkor ONY 2018. Salmonella infection – prevention and treatment by antibiotics and probiotic yeasts: a review. Microbiology. 164(11):1327–44.
Deen J, von Seidlein L, Andersen F, Elle N, White NJ, Lubell Y. Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis. czerwiec 2012;12(6):480–7.
Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis. czerwiec 2010;10(6):417–32.
Dougan G, Baker S. Salmonella enterica Serovar Typhi and the Pathogenesis of Typhoid Fever. Annu Rev Microbiol. 8 wrzesień 2014;68(1):317–36.
Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. maj 2004;82(5):346–53.
Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, i in. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health. październik 2014;2(10):e570-580.
Choroby zakaźne i zatrucia w Polsce w 2010 roku. 2010;164.
Wieczorek K, Osek J. Oporność przeciwdrobnoustrojowa Campylobacter i Salmonella izolowanych w krajach Unii Europejskiej w 2015 r. 2017;3.
Wieczorek K, Osek J. Antybiotykooporność Campylobacter i Salmonella izolowanych w krajach Unii Europejskiej w 2012 r. 2014;4.
Bronzwaer S. Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union. Clinical Microbiology and Infection. 1 czerwiec 2008;14(6):522–33.
Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the monitoring of zoonoses and zoonotic agents, amending Council Decision 90/424/EEC and repealing Council Directive 92/117/EEC [Internet]. https://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02003L0099-20130701. Queen’s Printer of Acts of Parliament; [cytowane 26 lipiec 2021]. Dostępne na: https://www.legislation.gov.uk/eudr/2003/99/article/4
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015. EFSA Journal. 2017;15(2):e04694.
Khan S, Chousalkar KK. Salmonella Typhimurium infection disrupts but continuous feeding of Bacillus based probiotic restores gut microbiota in infected hens. J Anim Sci Biotechnol. 2020;11:29.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 650
Number of citations: 0